Use of liposomes as drug delivery vehicles for treatment of melanoma
Open Access
- 13 July 2009
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 22 (4), 388-399
- https://doi.org/10.1111/j.1755-148x.2009.00581.x
Abstract
Melanoma is a progressive disease that claims many lives each year due to lack of therapeutics effective for the long‐term treatment of patients. Currently, the best treatment option is early detection followed by surgical removal. Better melanoma therapies that are effectively delivered to tumors with minimal toxicity for patients are urgently needed. Nanotechnologies provide one approach to encapsulate therapeutic agents leading to improvements in circulation time, enhanced tumor uptake, avoidance of the reticulo‐endothelial system, and minimization of toxicity. Liposomes in particular are a promising nanotechnology that can be used for more effective delivery of therapeutic agents to treat melanoma. Liposomes delivering chemotherapies, siRNA, asODNs, DNA, and radioactive particles are just some of the promising new nanotechnology based therapies under development for the treatment of melanoma that are discussed in this review.Keywords
This publication has 131 references indexed in Scilit:
- Targeting Melanoma Growth and Metastasis with Systemic Delivery of Liposome-Incorporated Protease-Activated Receptor-1 Small Interfering RNACancer Research, 2008
- Akt3 and Mutant V600EB-Raf Cooperate to Promote Early Melanoma DevelopmentCancer Research, 2008
- Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell GrowthJNCI Journal of the National Cancer Institute, 2008
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory TargetScience, 2008
- Understanding Signaling Cascades in Melanoma†Photochemistry and Photobiology, 2007
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Targeting Mitogen-Activated Protein Kinase/Extracellular Signal–Regulated Kinase Kinase in the Mutant (V600E) B-Raf Signaling Cascade Effectively Inhibits Melanoma Lung MetastasesCancer Research, 2006
- Perturbations of the AKT signaling pathway in human cancerOncogene, 2005
- Mutations of the BRAF gene in human cancerNature, 2002